Viewing Study NCT00855335

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:32 PM
Ignite Modification Date: 2026-02-02 @ 6:04 AM
Study NCT ID: NCT00855335
Status: COMPLETED
Last Update Posted: 2018-07-06
First Post: 2009-03-02
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women
Sponsor: Janssen Scientific Affairs, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV View
None HIV Infections View
None Pregnancy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV-1 View
None HIV View
None Pregnancy View
None Postpartum View
None Human immunodeficiency virus View
None PREZISTA View
None INTELENCE View
None NORVIR View
None TMC114 View
None TMC125 View
None darunavir View
None ritonavir View
None etravirine View
None rilpivirine View
None TMC278 View
None Cobicistat View
None treatment experienced View